Please assess the completion status of the following clinical trial:

Trial Title: Acetaminophen/Naproxen Sodium Dose Ranging Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~1. Males or females 17-50 years old~2. Weigh 100 pounds or greater and have a body mass index (BMI) of 17.5-35.4 (inclusive) at screening~3. Surgical removal of three or four third molars, of which, two must be mandibular impactions~4. Meets requirements for post-surgical pain level~5. Females of childbearing potential and males agree to contraceptive requirements of study~6. Have a negative urine drug screen at screening, and on day of surgical procedure~Exclusion Criteria:~1. Pregnant female, breastfeeding, trying to become pregnant or male with pregnant partner or partner currently trying to become pregnant~2. Have a known allergy or hypersensitivity to naproxen or other NSAIDs, including aspirin, or to acetaminophen, oxycodone or other opioids;~3. Not able to swallow whole large tablets or capsules~4. History of any condition (s) in investigator's opinion, may jeopardize subject safety, well-being and integrity of study~5. Use analgesics 5 or more times per week~6. History of chronic tranquilizer use, heavy drinking, or substance abuse, as judged by the investigator site staff, in the last 5 years~7. Use of any immunosuppressive drugs within 2 weeks of screening~8. History of endoscopically documented peptic ulcer disease or bleeding disorder in the last 2 years

- Gender: ALL
- Minimum Age: 17 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Acetaminophen/naproxen sodium Dose A (Type: EXPERIMENTAL): Acetaminophen/naproxen sodium Dose A administered as a single two-tablet dose.
- Acetaminophen/naproxen sodium Dose B (Type: EXPERIMENTAL): Acetaminophen/naproxen sodium Dose B administered as a single two-tablet dose.
- Acetaminophen/naproxen sodium Dose C (Type: EXPERIMENTAL): Acetaminophen/naproxen sodium Dose C administered as a single two-tablet dose.
- Acetaminophen/naproxen sodium Dose D (Type: EXPERIMENTAL): Acetaminophen/naproxen sodium Dose D administered as a single two-tablet dose.
- Acetaminophen/naproxen sodium Dose E (Type: EXPERIMENTAL): Acetaminophen/naproxen sodium Dose E administered as a single two-tablet dose.
- Placebo (Type: PLACEBO_COMPARATOR): Placebo tablets administered as a single two-tablet dose.

Based on this trial design, predict the completion outcome and termination type (if applicable).